Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 36.89
-5.31 %
$ 2.16 B
Market Cap
-9.66
P/E
BALANCE SHEET
776 M
ASSETS
153 M
LIABILITIES
623 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Twist Bioscience Corporation
| Current Assets | 424 M |
| Cash & Short-Term Investments | 336 M |
| Receivables | 44.1 M |
| Other Current Assets | 43.8 M |
| Non-Current Assets | 352 M |
| Long-Term Investments | 0 |
| PP&E | 203 M |
| Other Non-Current Assets | 149 M |
| Current Liabilities | 73.3 M |
| Accounts Payable | 14.1 M |
| Short-Term Debt | 14.9 M |
| Other Current Liabilities | 44.4 M |
| Non-Current Liabilities | 79.6 M |
| Long-Term Debt | 79.2 M |
| Other Non-Current Liabilities | 475 K |
Balance Sheet
Millions
| Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | Sep-2018 | Sep-2017 | Sep-2016 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 286.5 | 378.7 | 465.8 | 93.7 | 46.7 | 80.8 | 31.2 | 28.6 |
| Short Term Investments | 49.9 | 126.3 | 12.0 | 196.3 | 91.4 | 0 | 31.0 | 27.3 |
| Receivables | 44.1 | 40.3 | 28.5 | 26.4 | 12.1 | 5.4 | 2.3 | 0.7 |
| Inventory | 32.1 | 39.3 | 31.8 | 12.3 | 7.3 | 6.0 | 1.8 | 1.2 |
| Other Current Assets | 11.7 | 23.8 | 16.6 | 12.4 | 2.6 | 6.7 | 1.5 | 1.2 |
| Total Current Assets | 424.3 | 596.5 | 546.5 | 334.9 | 160.1 | 95.7 | 67.9 | 59.0 |
| PP&E | 203.4 | 214.4 | 105.7 | 59.2 | 20.8 | 12.3 | 14.8 | 14.6 |
| Intangible Assets | 54.5 | 59.7 | 18.3 | 0.3 | 0.5 | 0.7 | 0.9 | 1.1 |
| Goodwill | 85.8 | 85.8 | 22.4 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| Long Term Investments | 0 | 1.6 | 1.5 | 0.6 | 0.6 | 0.6 | 0.2 | 0.3 |
| Other Long Term Assets | 8.5 | 5.0 | 9.2 | 3.4 | 4.4 | 5.9 | 0.9 | 0.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 776.4 | 961.4 | 702.1 | 398.9 | 187.0 | 115.8 | 85.7 | 76.5 |
| LIABILITIES | ||||||||
| Accounts Payable | 14.1 | 20.1 | 14.9 | 4.8 | 9.8 | 7.5 | 2.8 | 2.3 |
| Short Term Debt | 14.9 | 27.3 | 18.0 | 16.2 | 3.3 | 2.5 | 0 | 1.4 |
| Other Current Liabilities | 40.0 | 36.1 | 27.7 | 14.3 | 17.3 | 8.5 | 6.6 | 5.0 |
| Total Current Liabilities | 73.3 | 90.7 | 63.1 | 36.0 | 30.4 | 18.5 | 9.5 | 8.7 |
| Long Term Debt | 79.2 | 81.3 | 53.2 | 26.2 | 4.4 | 7.2 | 9.2 | 9.8 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.5 | 60 K | 5.1 | 0.4 | 0.2 | 291.5 | 200.4 | 134.6 |
| Total Liabilities | 153.0 | 172.0 | 121.3 | 62.6 | 34.9 | 317.2 | 219.0 | 153.1 |
| EQUITY | ||||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (1 033.0) | (828.4) | (610.6) | (458.5) | (318.5) | (210.9) | (139.6) | (80.3) |
| Other Accumulative Comprehensive Income/Loss | (0.8) | (1.8) | 0.5 | 87 K | 0.2 | 87 K | 33 K | 9 K |
| Total Equity | 623.4 | 789.4 | 580.8 | 336.3 | 152.1 | (201.4) | (133.4) | (76.6) |
| Total Liabilities and Equity | 776.4 | 961.4 | 702.1 | 398.9 | 187.0 | 115.8 | 85.7 | 76.5 |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 56.9 | 53.9 | 48.3 | 39.2 | 27.5 | 26.6 | 18.8 | 18.8 |